I-Corps: Semi-automated adaptive upper extremity training for individuals post-stroke

该项目致力于对影响运动功能的神经障碍患者进行自动化、适应性康复和训练评估。随着人口年龄和中风后存活率的增加，需要提高运动治疗的有效性和效率。这个i-Corps团队的目标是在影响运动系统的神经障碍后改善手臂和手的功能，如中风、帕金森病和创伤性脑损伤(TBI)。I-Corps团队开发了一种名为Motion-Reach的新设备，该设备基于从3D摄像头获取的手部路径和手臂/躯干运动学的连续准确测量，提供自动化和高强度的手臂运动训练。这使得能够客观地评估达到成绩，最大限度地减少代偿运动，并进行适应性训练。具有运动伸展能力的适应性训练是直观的，可以由患者单独进行，也可以在半监督的临床环境中进行。Motion-Reach还提供快速、高精度且经过验证的评估。关于患者、治疗师和医疗保险提供者的逐期报告和整体报告被生成并保存在云中的数据库中。运动到达设备将扩大治疗师的时间可用性，因为该设备可以由无人监督的患者使用，并且不需要治疗师一对一的监督，因为它自动监控和提示患者正确地执行动作。客户群将包括以医院为基础的和私人理疗诊所。该设备可以销售到私人患者市场，由私人付费患者在物理治疗师的远程指导下在家中使用。治疗师的价值主张来自于让患者在没有治疗师直接监督的情况下进行高效的治疗练习的能力。对患者和患者的医疗保险提供者的价值主张是，与传统的中风康复和其他治疗技术相比，在更少的治疗疗程中实现最佳和可持续的改善。该团队的长期目标是开发个性化的神经康复，类似于临床药理学中成功的药物剂量控制。

This project addresses automated, adaptive-rehabilitation and training assessment for victims of neurological disorders that impact motor functions.As the population ages and survival rates post-stroke increase, there is a need to improve the effectiveness and efficiency of motor therapy. This I-Corps team's goal is to improve arm and hand function following neurological disorders that affect the motor system, such as stroke, Parkinson's disease, and traumatic brain injury (TBI). This I-Corps team has developed a new device, MOTION-REACH, that provides automated and high-intensity arm motor training based on continuous accurate measurements of hand path and arm/trunk kinematics acquired from a 3D camera. This allows for objective assessment of reaching performance, minimization of compensatory movements, and adaptive training. Adaptive training with MOTION-REACH is intuitive and can be performed by patients alone or in a semi-supervised clinical environment. MOTION-REACH also provides fast, high-precision, and validated assessments. Session-by-session reports and overall reports for the patient, the therapist, and the health insurance provider are generated and saved on a database in the cloud.The MOTION-REACH device will expand therapist time availability because the device can be used by an unsupervised patient and does not require 1-to-1 supervision by the therapist, as it automatically monitors and prompts patients to perform movements correctly. Customer segments will include hospital-based and private physical therapy clinics. The device can be sold into the private patient marketplace, to be used in-home by private-pay patients under the remote guidance of a physical therapist. The value proposition for the therapist derives from the ability to have patients performing highly effective therapeutic exercises without direct therapist supervision. The value proposition for the patient and the patient's medical insurance provider is that optimal and sustainable improvement is achieved in fewer therapy sessions than with traditional stroke recovery and other therapy techniques. This team's long-term goal is to develop personalized neurorehabilitation, similar to the successful drug dosing control in clinical pharmacology.